<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <id>https://finance.naver.com/news/news_list.naver?mode=LSS3D&amp;section_id=101&amp;section_id2=258&amp;section_id3=402</id>
    <title>네이버 금융 ─ 뉴스 ─ 기업 종목분석</title>
    <updated>2021-10-22T02:03:05.235Z</updated>
    <generator>https://github.com/jpmonette/feed</generator>
    <icon>https://finance.naver.com/news/favicon.ico</icon>
    <entry>
        <title type="html"><![CDATA[게임株들의 반격…코스닥 시총경쟁 재점화]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004987305&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004987305&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1"/>
        <updated>2021-10-22T02:01:23.472Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004987305&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1" title="게임株들의 반격…코스닥 시총경쟁 재점화">게임株들의 반격…코스닥 시총경쟁 재점화</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[특징주] 인적 분할 앞둔 SK텔레콤, 기업가치 상승 기대감에 4% ↑]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0003976301&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0003976301&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1"/>
        <updated>2021-10-22T02:01:23.475Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0003976301&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1" title="[특징주] 인적 분할 앞둔 SK텔레콤, 기업가치 상승 기대감에 4% ↑">[특징주] 인적 분할 앞둔 SK텔레콤, 기업가치 상승 기대감에 4% ↑</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[특징주]차백신연구소, 상장 첫날 25% 급등]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004987280&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004987280&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1"/>
        <updated>2021-10-22T02:01:23.475Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004987280&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1" title="[특징주]차백신연구소, 상장 첫날 25% 급등">[특징주]차백신연구소, 상장 첫날 25% 급등</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[컴투스, 美 캔디 디지털 투자…블록체인 사업 강화]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004868252&amp;office_id=009&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004868252&amp;office_id=009&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1"/>
        <updated>2021-10-22T02:01:23.475Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004868252&amp;office_id=009&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1" title="컴투스, 美 캔디 디지털 투자…블록체인 사업 강화">컴투스, 美 캔디 디지털 투자…블록체인 사업 강화</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[이지스운용, ‘4년 연속’ 글로벌 ESG 평가 최고 등급 획득]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004727328&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004727328&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1"/>
        <updated>2021-10-22T02:01:23.475Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004727328&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1" title="이지스운용, ‘4년 연속’ 글로벌 ESG 평가 최고 등급 획득">이지스운용, ‘4년 연속’ 글로벌 ESG 평가 최고 등급 획득</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[유니테크노, 베트남 빈그룹 '5GWh' 배터리셀 공장 확정에 수혜 기대]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004727322&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004727322&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1"/>
        <updated>2021-10-22T02:01:23.480Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004727322&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1" title="유니테크노, 베트남 빈그룹 '5GWh' 배터리셀 공장 확정에 수혜 기대">유니테크노, 베트남 빈그룹 '5GWh' 배터리셀 공장 확정에 수혜 기대</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[바이오플러스, 차세대 단백질 의약품 개발 '유비프로틴' 경영권 확보]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004987256&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004987256&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1"/>
        <updated>2021-10-22T02:01:23.482Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004987256&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211022&amp;page=1" title="바이오플러스, 차세대 단백질 의약품 개발 '유비프로틴' 경영권 확보">바이오플러스, 차세대 단백질 의약품 개발 '유비프로틴' 경영권 확보</a>]]></content>
    </entry>
</feed>